AVALO THERAPEUTICS, INC. Inventory
AVALO THERAPEUTICS, INC. (AVTX) had Inventory of $0 as of 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2024-03-29
- 2023-12-31: Inventory, Net $0.00.
- 2023-09-30: Inventory, Net $0.00.
- 2023-06-30: Inventory, Net $18.00K.
- 2023-03-31: Inventory, Net $19.00K.
| Period end | Inventory, Net | Inventory, Net as first filed |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-03-29 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $18.00K 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $19.00K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $20.00K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $22.00K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $23.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $25.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $38.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $16.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $20.00K 10-Q · filed 2021-08-02 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $3.00K 10-K · filed 2022-03-02 | $3.14K 10-K · filed 2021-03-08 |
| 2020-09-30 | $9.06K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $12.20K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $16.28K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $21.33K 10-K · filed 2021-03-08 | |
| 2019-09-30 | $402.27K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $617.61K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.05M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $317.92K 10-K · filed 2020-03-11 | $1.11M 10-K · filed 2019-03-18 |
| 2018-09-30 | $1.06M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $1.54M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $3.44M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $382.15K 10-K · filed 2019-03-18 | |
| 2016-12-31 | $0.00 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |